"Anticarcinogenic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved.
| Descriptor ID |
D016588
|
| MeSH Number(s) |
D27.505.696.706.018 D27.505.954.248.125 D27.720.799.018
|
| Concept/Terms |
Anticarcinogenic Agents- Anticarcinogenic Agents
- Agents, Anticarcinogenic
- Anti-Carcinogenic Drugs
- Anti Carcinogenic Drugs
- Drugs, Anti-Carcinogenic
- Anticarcinogens
- Anti-Carcinogenic Agents
- Agents, Anti-Carcinogenic
- Anti Carcinogenic Agents
- Anticarcinogenic Drugs
- Drugs, Anticarcinogenic
Anticarcinogenic Effect- Anticarcinogenic Effect
- Effect, Anticarcinogenic
- Anti-Carcinogenic Effects
- Anti Carcinogenic Effects
- Effects, Anti-Carcinogenic
- Anticarcinogenic Effects
- Effects, Anticarcinogenic
- Anti-Carcinogenic Effect
- Anti Carcinogenic Effect
- Effect, Anti-Carcinogenic
|
Below are MeSH descriptors whose meaning is more general than "Anticarcinogenic Agents".
Below are MeSH descriptors whose meaning is more specific than "Anticarcinogenic Agents".
This graph shows the total number of publications written about "Anticarcinogenic Agents" by people in this website by year, and whether "Anticarcinogenic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anticarcinogenic Agents" by people in Profiles.
-
Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services Task Force. Ann Intern Med. 2016 Jun 21; 164(12):814-25.
-
Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2016 06 21; 164(12):777-86.
-
Diet and upper gastrointestinal malignancies. Gastroenterology. 2015 May; 148(6):1234-1243.e4.
-
Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis. Nutr Rev. 2013 Jul; 71(7):474-82.
-
Genetic variation in the lipoxygenase pathway and risk of colorectal neoplasia. Genes Chromosomes Cancer. 2013 May; 52(5):437-49.
-
Breast cancer anxiety's associations with responses to a chemoprevention decision aid. Soc Sci Med. 2013 Jan; 77:13-9.
-
Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology. 2012 Mar; 142(3):442-452.e5; quiz e22-3.
-
Women's interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid. Breast Cancer Res Treat. 2011 Jun; 127(3):681-8.
-
Statin use and cancer risk: a comprehensive review. Expert Opin Drug Saf. 2010 Jul; 9(4):603-21.
-
Re: Lung cancer risk among female textile workers exposed to endotoxin. J Natl Cancer Inst. 2010 Jun 16; 102(12):913-4.